This conference is focused on technology, development and application. Topics include targeted mutagenesis, site-specific recombinases and integrases, and new methods for regulating gene expression. Late-breaking technologies will also be discussed.
Organizers: Mark Magnuson, MD and Chris Wright, DPhil; Vanderbilt University
Keynote: Allan Bradley, PhD; Sanger Institute
Confirmed Speakers include:
Kimi Araki, PhD; Kumamoto University
Michele Calos, PhD; Stanford University
Nicholas Gale, PhD; Regeneron Pharmaceuticals
David Largaespada, PhD; University of Minnesota
Ray MacDonald, PhD; University of Texas
Andy McMahon, PhD; Harvard University
Andras Nagy, PhD; Rockefeller University
David Piston, PhD; Vanderbilt University
Brian Sauer, PhD; Stowers Institute for Medical Research
Heidi Scrable, PhD; University of Virginia
William Skarnes, PhD; The Wellcome Trust Sanger Institute
Philippe Soriano, PhD; Fred Hutchinson Cancer Research Center
A. Francis Stewart, PhD; Biotec, Technische Universitaet Dresden
Greg Van Duyne, PhD; University of Pennsylvania
Tony Wynshaw-Boris, PhD; University of California, San Diego